Search research articles
Contact Us
Filters
Showing results (41-50 of 66) with videos related to
Page
of 7
Sort By:
The Pediatric Infectious Disease Journal
|
July 1, 2015
Administration Time for the First Dose of Antimicrobials in Episodes of Fever and Neutropenia in Children With Cancer
Verónica De la Maza, Daniela Simian, Magdalena Castro, et al.
Molecules (Basel, Switzerland)
|
March 28, 2024
Structure, Absolute Configuration, Antiproliferative and Phytotoxic Activities of Icetexane and Abietane Diterpenoids from <i>Salvia carranzae</i> and Chemotaxonomic Implications
Celia Bustos-Brito, Juan Pablo Torres-Medicis, Brenda Y Bedolla-García, et al.
European Journal of Cancer Care
|
July 25, 2020
Impact of a structured educational programme for caregivers of children with cancer on parental knowledge of the disease and paediatric clinical outcomes during the first year of treatment
Verónica De la Maza, Macarena Manriquez, Magdalena Castro, et al.
Revista Chilena De Pediatria
|
November 24, 2015
[Impact of an educational program for parents of children with cancer on the increased knowledge of their children's disease and the decrease in anxiety]
Verónica de la Maza L, Maria Fernández C, Lorena Concha R, et al.
Lancet Regional Health. Americas
|
April 30, 2026
Health care utilization and cost implications of Chile's 2024 nirsevimab strategy for RSV prevention: a counterfactual analysis
Denis Sauré, Amal Zgheib, Juan Pablo Torres, et al.
JAMA Network Open
|
April 10, 2026
Nirsevimab in High-Risk Infants in a Respiratory Syncytial Virus Prevention Strategy
Denis Sauré, Juan Pablo Torres, Marcel Goic, et al.
Respiratory Research
|
September 17, 2010
Respiratory syncytial virus (RSV) RNA loads in peripheral blood correlates with disease severity in mice
Juan Pablo Torres, Ana M Gomez, Shama Khokhar, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 11, 2008
MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus
Vijay G Bhoj, Qinmiao Sun, Elizabeth J Bhoj, et al.
The Lancet. Infectious Diseases
|
June 13, 2025
Effectiveness and impact of nirsevimab in Chile during the first season of a national immunisation strategy against RSV (NIRSE-CL): a retrospective observational study
Juan Pablo Torres, Denis Sauré, Marcel Goic, et al.
Frontiers in Immunology
|
May 31, 2023
Monoclonal antibodies for prophylaxis and therapy of respiratory syncytial virus, SARS-CoV-2, human immunodeficiency virus, rabies and bacterial infections: an update from the World Association of Infectious Diseases and Immunological Disorders and the Italian Society of Antinfective Therapy
Susanna Esposito, Gayatri Amirthalingam, Matteo Bassetti, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 66) with videos related to
Sort By:
Page
of 7
The Pediatric Infectious Disease Journal
|
July 1, 2015
Administration Time for the First Dose of Antimicrobials in Episodes of Fever and Neutropenia in Children With Cancer
Verónica De la Maza, Daniela Simian, Magdalena Castro, et al.
Molecules (Basel, Switzerland)
|
March 28, 2024
Structure, Absolute Configuration, Antiproliferative and Phytotoxic Activities of Icetexane and Abietane Diterpenoids from <i>Salvia carranzae</i> and Chemotaxonomic Implications
Celia Bustos-Brito, Juan Pablo Torres-Medicis, Brenda Y Bedolla-García, et al.
European Journal of Cancer Care
|
July 25, 2020
Impact of a structured educational programme for caregivers of children with cancer on parental knowledge of the disease and paediatric clinical outcomes during the first year of treatment
Verónica De la Maza, Macarena Manriquez, Magdalena Castro, et al.
Revista Chilena De Pediatria
|
November 24, 2015
[Impact of an educational program for parents of children with cancer on the increased knowledge of their children's disease and the decrease in anxiety]
Verónica de la Maza L, Maria Fernández C, Lorena Concha R, et al.
Lancet Regional Health. Americas
|
April 30, 2026
Health care utilization and cost implications of Chile's 2024 nirsevimab strategy for RSV prevention: a counterfactual analysis
Denis Sauré, Amal Zgheib, Juan Pablo Torres, et al.
JAMA Network Open
|
April 10, 2026
Nirsevimab in High-Risk Infants in a Respiratory Syncytial Virus Prevention Strategy
Denis Sauré, Juan Pablo Torres, Marcel Goic, et al.
Respiratory Research
|
September 17, 2010
Respiratory syncytial virus (RSV) RNA loads in peripheral blood correlates with disease severity in mice
Juan Pablo Torres, Ana M Gomez, Shama Khokhar, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 11, 2008
MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus
Vijay G Bhoj, Qinmiao Sun, Elizabeth J Bhoj, et al.
The Lancet. Infectious Diseases
|
June 13, 2025
Effectiveness and impact of nirsevimab in Chile during the first season of a national immunisation strategy against RSV (NIRSE-CL): a retrospective observational study
Juan Pablo Torres, Denis Sauré, Marcel Goic, et al.
Frontiers in Immunology
|
May 31, 2023
Monoclonal antibodies for prophylaxis and therapy of respiratory syncytial virus, SARS-CoV-2, human immunodeficiency virus, rabies and bacterial infections: an update from the World Association of Infectious Diseases and Immunological Disorders and the Italian Society of Antinfective Therapy
Susanna Esposito, Gayatri Amirthalingam, Matteo Bassetti, et al.
Page
of 7